OraSure Technologies is a medical device and healthcare diagnostics company that develops, manufactures, and markets point-of-care testing solutions and sample collection tools. The company is a pioneer in non-invasive oral fluid testing and aims to decentralize diagnostics to improve global health outcomes. Its portfolio includes rapid diagnostic tests for infectious diseases (such as HIV, HCV, and Syphilis), drugs of abuse testing, and advanced sample management solutions that support genomic, metabolomic, and microbiome research. OraSure also operates through its subsidiaries, including DNA Genotek, Sherlock Biosciences, and BioMedomics.
